Pirfenidone and candesartan ameliorate morphological damage in mild chronic anti-GBM nephritis in rats. (Q45161152)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15561744%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Pirfenidone and candesartan ameliorate morphological damage in mild chronic anti-GBM nephritis in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15561744%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15561744%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Øyvind Vaagnes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15561744%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Solomon B Margolin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15561744%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Bjarne M Iversen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15561744%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Terje Forslund

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15561744%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

23 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15561744%20AND%20SRC:MED&resulttype=core&format=json

Nephrology Dialysis Transplantation

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15561744%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15561744%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

71-82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15561744%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15561744%20AND%20SRC:MED&resulttype=core&format=json

Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH562

Pirfenidone attenuates ischaemia-reperfusion injury in the rat small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH562

Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH562

Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH562

Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH562

Role of reactive oxygen species in glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH562

Determinants of glomerular filtration in experimental glomerulonephritis in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH562